Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review

Checkpoint inhibitors are monoclonal antibodies that elicit an anti-tumor response by stimulating immune system. Their use has improved the treatment of different types of cancer such as melanoma, breast carcinoma, lung, stomach, colon, liver, renal cell carcinoma, and Hodgkin’s lymphoma, but severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Profili, Nicia I., Castelli, Roberto, Gidaro, Antonio, Merella, Alessandro, Manetti, Roberto, Palmieri, Giuseppe, Maioli, Margherita, Delitala, Alessandro P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419837/
https://www.ncbi.nlm.nih.gov/pubmed/37568563
http://dx.doi.org/10.3390/jcm12155161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419837/
https://www.ncbi.nlm.nih.gov/pubmed/37568563
http://dx.doi.org/10.3390/jcm12155161

Ejemplares similares